Research and Development
Novartis’ Ilaris gets US FDA breakthrough therapy designation to treat fever syndromes
April 27, 2016 Business Services, Research and Development Breakthrough Therapy Designation, Novartis, US FDA, periodic fever syndromes
Eisai poaches senior Pfizer and Sanofi execs for neurology group
April 26, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Eisai, Pfizer, Sanofi, appointments, hawthorne, zaim
Northern Powerhouse life sciences contributing £10 billion to UK economy, says minister
April 26, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Jobs, Northern Powerhouse, contribution, economy, exporting, george freeman, investment, life sciences, minister, north
US panel says Sarepta’s trial DMD drug not proven effective
April 26, 2016 Manufacturing and Production, Research and Development DMD, US FDA, drug trial, sarepta
Bayer’s earnings beat estimates as blockbusters shine
April 26, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Eylea, Q1, Xarelto, blockbusters, growth, results, sales
AstraZeneca’s COPD therapy gets US FDA approval
April 26, 2016 Research and Development, Sales and Marketing AstraZeneca, COPD, US FDA, drug approval
EU grants approval for Gilead’s HIV treatment Descovy
April 26, 2016 Manufacturing and Production, Research and Development EU, HIV, approval, descovy, taf
Valeant names Joseph Papa as new chief executive officer
April 25, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Chairman, Valeant, joseph papa, new, new ceo, papa, pearson
FDA, WHO criticise integrity of data at contract research firm Semler
April 25, 2016 Research and Development, Sales and Marketing FDA, India, WHO, World Health Organisation, semler, semler research
Weekly Movers: PTC Therapeutics, Celator Pharmaceuticals, Chiasma, Sarepta and more…
April 25, 2016 Research and Development, Sales and Marketing
Pfizer, GSK’s anti-smoking drugs not linked to increase in serious neuropsychiatric adverse events – Study
April 25, 2016 Research and Development, Sales and Marketing
Merck’s colorectal cancer drug meets primary endpoint in Phase III study
April 25, 2016 Research and Development, Sales and Marketing Erbitux, Merck, Serono, cancer drugs, colorectal cancer, increased survival, oncology, phase 3, phase III
AbbVie announces further industry and academic collaborations
April 22, 2016 Medical Communications, Research and Development AbbVie, collaboration, commercialisation, cytomx, partnership, research, university of chicago
Novartis muscular drug fails in Phase III trials
April 22, 2016 Medical Communications, Research and Development FDA, Novartis, bimagrumab, breakthrough, morphosys, muscular, phase III
Bluebird Bio gene therapy posts encouraging results in treatment of rare brain disease
April 21, 2016 Medical Communications, Research and Development Bluebird Bio, Phase II, gene therapy, lenti-d, paediatric, phase 2, phase 3, phase III, rare brain disease
